Clinical Trial Update: A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating flexible-dose brexpiprazole as monotherapy or in combination for adults with post-traumatic stress disorder (PTSD) completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: COMPLETED | Results posted: 2021-12-08